Fig. 5 | Scientific Reports

Fig. 5

From: Exploring the potential mechanisms of anti-pulmonary fibrosis effects of Luo Han Guo via network pharmacology, molecular docking, and experimental validation

Fig. 5

Molecular docking visualization of LHG active compounds bound to key target proteins. ( A) Binding mode of SRC with kaempferol. (B) Binding mode of SRC with Mogrol. (C) Binding mode of SRC with 11-oxomogroside V. (D) Binding mode of AKT1 with kaempferol. (E) Binding mode of AKT1 with Mogrol. (F) Binding mode of AKT1 with 11-oxomogroside V. ( G) Binding mode of STAT3 with Mogrol. (H) Binding mode of STAT3 with kaempferol. (I) Binding mode of STAT3 with 11-oxomogroside V.

Back to article page